reviewNature BiotechnologySep 1, 2005Closed access

Arming antibodies: prospects and challenges for immunoconjugates

AMAnna M. WuPDPeter D. Senter

University of California, Los Angeles · Seagen (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,040
total citations
FWCI
58.51
Percentile
100%
References
104
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Gemtuzumab ozogamicin
  • Ibritumomab tiuxetan
  • Monoclonal antibody
  • Immunoconjugate
  • Conjugate
  • Pharmacology
  • Biodistribution
  • Radioimmunotherapy
No related works found for this paper.

Funding